← Back to Intel
Insider ActivityCYTK
Kaye Edward M. MD, Director at CYTOKINETICS INC, sold $223K of CYTK
Updated Jun 18, 2026
Kaye Edward M. MD
Director
CYTOKINETICS INC ·
$CYTK
Transaction Details
| Insider | Kaye Edward M. MD |
|---|---|
| Title | Director |
| Company | CYTOKINETICS INC |
| Ticker | CYTK |
| Transaction Type | Sale |
| Transaction Date | 2026-06-01 |
| Shares Traded | 2,933 |
| Price Per Share | $76.09 |
| Total Value | $223K |
| Filed Date | 2026-06-01 |
| Accession Number | 0001061983-26-000066 |
Ownership Context
| Shares Owned After Transaction | 10,283 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001061983-26-000066
Other Insider Trades — CYTK
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Blum Robert I | President & CEO, Director | sold | $528K | 2026-06-15 |
| Malik Fady Ibraham | EVP Research & Development | sold | $238K | 2026-06-09 |
| Malik Fady Ibraham | EVP Research & Development | traded | $27K | 2026-06-09 |
| Callos Andrew | EVP, Chief Commercial Officer | sold | $1.1M | 2026-06-01 |
| Callos Andrew | EVP, Chief Commercial Officer | traded | $349K | 2026-06-01 |
| PARSHALL B LYNNE | Director | sold | $370K | 2026-06-01 |
| PARSHALL B LYNNE | Director | traded | — | 2026-05-27 |
| WIERENGA WENDELL | Director | traded | — | 2026-05-27 |
| PARSHALL B LYNNE | Director | traded | — | 2026-05-27 |
| Daly James M | Director | traded | — | 2026-05-27 |
Other Trades by Kaye Edward M. MD
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | traded | — | 2026-06-03 |
| CYTK | CYTOKINETICS INC | traded | — | 2026-05-27 |
| CYTK | CYTOKINETICS INC | traded | — | 2026-05-27 |
| CYTK | CYTOKINETICS INC | traded | $12K | 2026-04-15 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for CYTK — CYTOKINETICS INC →
Track CYTK insider activity in real time on The Wire →
Get alerts when Kaye Edward M. MD files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 18, 2026 at 07:05 UTC